← All organizations

Calcilytix Therapeutics, Inc.

For profit

Also known as: Calcilytix Therapeutics, Inc. | Calcilytix Therapeutics, Inc., a BridgeBio company

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Aug 31, 2025

Timeline

2010s

Jun 1, 2018
Calcilytix Therapeutics, Inc.— Founded

Drugs by trial phase (1 distinct, 3 trials)

Phase 3 (1 own, 0 via acquisition)

encaleret

Indications

Studied for

Recent trials (5)

NCT07080385Lead sponsorPhase 2/Phase 3Aug 31, 2025
NCT07080385OfficialPhase 2/Phase 3Aug 31, 2025
NCT05680818Lead sponsorPhase 3Jan 6, 2023
NCT05680818Study directorPhase 3Jan 6, 2023
NCT04581629Lead sponsorPhase 2Sep 15, 2020

Details

Founded: San Francisco, CA, US Jun 1, 2018
Last known activity: Aug 31, 2025